Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validation
In: European Journal of Cancer, Jg. 39 (2003), S. 675-683
serialPeriodical
Zugriff:
Titel: |
Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validation
|
---|---|
Autor/in / Beteiligte Person: | Moneta, D ; Geroni, C ; Valota, O ; Grossi, P ; e Jonge, Maja ; Brughera, M ; Colajori, E ; Ghielmini, M ; Sessa, C ; Oncology, Medical |
Link: | |
Zeitschrift: | European Journal of Cancer, Jg. 39 (2003), S. 675-683 |
Veröffentlichung: | 2003 |
Medientyp: | serialPeriodical |
ISSN: | 0959-8049 (print) ; 1879-0852 (print) |
DOI: | 10.1016/s0959-8049(02)00812-2 |
Sonstiges: |
|